Total Funding
64
83
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
69878
Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).
- Mårten Winge: Chief Executive Officer
About the Company
Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC). The company employs an antibody-based technique based on the genetic profile of each patient's tumor that destroys tumor cells while leaving other normal cells alone in the body. The company offers patients a low-cost, effective medication while
minimizing the danger of unwanted effects.
